Published in Hypertension on July 23, 2007
A new conceptual paradigm for the haemodynamics of salt-sensitive hypertension: a mathematical modelling approach. J Physiol (2012) 1.76
Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure. Exp Physiol (2009) 1.74
Localization of NADPH oxidase in sympathetic and sensory ganglion neurons and perivascular nerve fibers. Auton Neurosci (2009) 1.48
Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension (2010) 1.39
Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol (2009) 1.35
Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep (2011) 1.29
Dietary sodium and health: more than just blood pressure. J Am Coll Cardiol (2015) 1.11
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2011) 1.10
Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension? Exp Physiol (2010) 1.05
Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure. Hypertension (2008) 1.04
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension (2013) 1.04
Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat. Am J Physiol Heart Circ Physiol (2008) 1.02
Portal osmopressor mechanism linked to transient receptor potential vanilloid 4 and blood pressure control. Hypertension (2010) 0.99
A mathematical model of salt-sensitive hypertension: the neurogenic hypothesis. J Physiol (2014) 0.99
Central angiotensin II has catabolic action at white and brown adipose tissue. Am J Physiol Endocrinol Metab (2011) 0.98
Excess dietary salt intake alters the excitability of central sympathetic networks. Physiol Behav (2010) 0.97
Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension. Am J Physiol Heart Circ Physiol (2011) 0.94
Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension. Am J Physiol Heart Circ Physiol (2011) 0.94
Neurogenic and sympathoexcitatory actions of NaCl in hypertension. Curr Hypertens Rep (2013) 0.92
Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol. Am J Physiol Regul Integr Comp Physiol (2011) 0.89
Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats. Hypertension (2008) 0.87
Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Neuroscience (2010) 0.87
Ang II-salt hypertension depends on neuronal activity in the hypothalamic paraventricular nucleus but not on local actions of tumor necrosis factor-α. Hypertension (2013) 0.86
(In)activity-dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity. J Appl Physiol (1985) (2011) 0.85
Renal denervation attenuates progression of atherosclerosis in apolipoprotein E-deficient mice independent of blood pressure lowering. Hypertension (2015) 0.84
Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function. J Am Heart Assoc (2015) 0.84
Effect of global and regional sympathetic blockade on arterial pressure during water deprivation in conscious rats. Am J Physiol Heart Circ Physiol (2012) 0.83
The neurogenic phase of angiotensin II-salt hypertension is prevented by chronic intracerebroventricular administration of benzamil. Physiol Rep (2014) 0.83
Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity. J Am Heart Assoc (2013) 0.83
(In)activity-related neuroplasticity in brainstem control of sympathetic outflow: unraveling underlying molecular, cellular, and anatomical mechanisms. Am J Physiol Heart Circ Physiol (2015) 0.83
A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin. Am J Physiol Regul Integr Comp Physiol (2014) 0.82
Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat. Am J Physiol Heart Circ Physiol (2013) 0.82
Oxygen in the regulation of intestinal epithelial transport. J Physiol (2014) 0.82
Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2008) 0.81
Discharge of RVLM vasomotor neurons is not increased in anesthetized angiotensin II-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2013) 0.79
Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension. Oncotarget (2016) 0.79
Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration. Am J Physiol Heart Circ Physiol (2014) 0.78
What can we learn about neural control of the cardiovascular system by studying rhythms in sympathetic nerve activity? Int J Psychophysiol (2015) 0.78
Macrophage depletion lowers blood pressure and restores sympathetic nerve α2-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2015) 0.77
Sympathetic innervation of the splanchnic region mediates the beneficial hemodynamic effects of 8-OH-DPAT in hemorrhagic shock. Am J Physiol Regul Integr Comp Physiol (2012) 0.77
Synapses, signals, CDs, and cytokines: interactions of the autonomic nervous system and immunity in hypertension. Circ Res (2012) 0.76
Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome. PLoS One (2015) 0.76
Sympathoexcitation in ANG II-salt hypertension involves reduced SK channel function in the hypothalamic paraventricular nucleus. Am J Physiol Heart Circ Physiol (2015) 0.76
Impaired function of prejunctional adenosine A1 receptors expressed by perivascular sympathetic nerves in DOCA-salt hypertensive rats. J Pharmacol Exp Ther (2013) 0.76
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans. J Appl Physiol (1985) (2010) 0.75
Long-Term Blood Pressure Control Effect of Celiac Plexus Block with Botulinum Toxin. Toxins (Basel) (2016) 0.75
Role of CaMKII in Ang-II-dependent small artery remodeling. Vascul Pharmacol (2016) 0.75
A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat Commun (2016) 0.75
Possible role for brain prostanoid pathways in the development of angiotensin II-salt hypertension in rats. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
High Salt Intake Augments Excitability of PVN Neurons in Rats: Role of the Endoplasmic Reticulum Ca(2+) Store. Front Neurosci (2017) 0.75
Hepatic and renal mechanisms underlying the osmopressor response. Auton Neurosci (2017) 0.75
Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep (2007) 2.23
Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation. Hypertension (2013) 2.04
A new conceptual paradigm for the haemodynamics of salt-sensitive hypertension: a mathematical modelling approach. J Physiol (2012) 1.76
Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure. Exp Physiol (2009) 1.74
Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation (2003) 1.65
Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation (2003) 1.59
Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats. J Hypertens (2002) 1.47
Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension (2010) 1.39
Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol (2009) 1.35
Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep (2011) 1.29
Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol (2008) 1.26
Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms. Hypertension (2006) 1.25
Hypertension caused by prenatal testosterone excess in female sheep. Am J Physiol Endocrinol Metab (2007) 1.15
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2011) 1.10
Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol (2005) 1.09
Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension? Exp Physiol (2010) 1.05
Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats. Hypertension (2004) 1.04
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension (2013) 1.04
Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1, and systemic hypertension at modest altitude. Hypertension (2008) 1.03
Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress. Am J Physiol Regul Integr Comp Physiol (2010) 1.02
5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther (2008) 1.02
Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat. Am J Physiol Heart Circ Physiol (2008) 1.02
Increased O2*- production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension (2004) 1.02
The role of the subfornical organ in angiotensin II-salt hypertension in the rat. Exp Physiol (2011) 1.02
Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo. Am J Physiol Regul Integr Comp Physiol (2005) 1.00
Chemerin connects fat to arterial contraction. Arterioscler Thromb Vasc Biol (2013) 0.99
Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats. Auton Neurosci (2003) 0.99
NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension (2003) 0.98
Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension (2003) 0.98
Large-conductance Ca2+-activated K+ channel beta1-subunit knockout mice are not hypertensive. Am J Physiol Heart Circ Physiol (2010) 0.97
A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) (2007) 0.97
Renal denervation chronically lowers arterial pressure independent of dietary sodium intake in normal rats. Am J Physiol Heart Circ Physiol (2003) 0.96
Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2007) 0.96
Renal denervation causes chronic hypotension in rats: role of beta1-adrenoceptor activity. Clin Exp Pharmacol Physiol (2005) 0.96
Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension. Am J Physiol Heart Circ Physiol (2011) 0.94
Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension. Am J Physiol Heart Circ Physiol (2011) 0.94
Arteries and veins desensitize differently to endothelin. J Cardiovasc Pharmacol (2004) 0.92
Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists. Br J Pharmacol (2002) 0.92
Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol (2002) 0.91
Does whole body autoregulation mediate the hemodynamic responses to increased dietary salt in rats with clamped ANG II? Am J Physiol Heart Circ Physiol (2003) 0.90
A role for benzamil-sensitive proteins of the central nervous system in the pathogenesis of salt-dependent hypertension. Clin Exp Pharmacol Physiol (2008) 0.90
Differences in sympathetic neuroeffector transmission to rat mesenteric arteries and veins as probed by in vitro continuous amperometry and video imaging. J Physiol (2007) 0.90
Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits. Exp Physiol (2007) 0.90
Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. PLoS One (2013) 0.89
Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol. Am J Physiol Regul Integr Comp Physiol (2011) 0.89
Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. J Pharmacol Exp Ther (2006) 0.88
Cardiovascular depression in rats exposed to inhaled particulate matter and ozone: effects of diet-induced metabolic syndrome. Environ Health Perspect (2013) 0.88
Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure. Vascul Pharmacol (2005) 0.88
Effect of intracerebroventricular benzamil on cardiovascular and central autonomic responses to DOCA-salt treatment. Am J Physiol Regul Integr Comp Physiol (2010) 0.88
Vascular BK channel deficiency exacerbates organ damage and mortality in endotoxemic mice. J Cardiovasc Pharmacol (2012) 0.87
Mild DOCA-salt hypertension: sympathetic system and role of renal nerves. Am J Physiol Heart Circ Physiol (2011) 0.87
Activation of potassium channels by tempol in arterial smooth muscle cells from normotensive and deoxycorticosterone acetate-salt hypertensive rats. Hypertension (2006) 0.87
Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol (2002) 0.86
Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension (2006) 0.85
Increased sympathetic venoconstriction and reactivity to norepinephrine in mesenteric veins in anesthetized DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2007) 0.85
Regulation of corticosterone production by vasopressin during water restriction and after drinking in rats. Neuroendocrinology (2003) 0.85
Impaired function of alpha2-adrenergic autoreceptors on sympathetic nerves associated with mesenteric arteries and veins in DOCA-salt hypertension. Am J Physiol Heart Circ Physiol (2003) 0.85
5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat. J Pharmacol Exp Ther (2002) 0.84
Big ET-1 processing into vasoactive peptides in arteries and veins. Vascul Pharmacol (2007) 0.84
OVLT lesion decreases basal arterial pressure and the chronic hypertensive response to AngII in rats on a high-salt diet. Physiol Rep (2013) 0.84
Endothelin-1-induced contraction in veins is independent of hydrogen peroxide. Am J Physiol Heart Circ Physiol (2005) 0.84
Effect of global and regional sympathetic blockade on arterial pressure during water deprivation in conscious rats. Am J Physiol Heart Circ Physiol (2012) 0.83
Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Hypertension (2002) 0.83
Sympathetic signatures of cardiovascular disease: a blueprint for development of targeted sympathetic ablation therapies. Hypertension (2012) 0.83
Alterations in sympathetic neuroeffector transmission to mesenteric arteries but not veins in DOCA-salt hypertension. Auton Neurosci (2009) 0.83
Pharmacological endothelin receptor interaction does not occur in veins from ET(B) receptor deficient rats. Vascul Pharmacol (2008) 0.83
Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat. Am J Physiol Heart Circ Physiol (2013) 0.82
The effect of cardiac sympathetic denervation through bilateral stellate ganglionectomy on electrical properties of the heart. Am J Physiol Heart Circ Physiol (2011) 0.82
The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure. FASEB J (2014) 0.81
Commentary on 'Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure'. Exp Physiol (2009) 0.80
Altered L-type Ca2+ channel activity contributes to exacerbated hypoperfusion and mortality in smooth muscle cell BK channel-deficient septic mice. Am J Physiol Regul Integr Comp Physiol (2014) 0.80
Developmental programming of cardiovascular disorders: focus on hypertension. Rev Endocr Metab Disord (2007) 0.80
Preferential myosin heavy chain isoform B Expression may contribute to the faster velocity of contraction in veins versus arteries. J Vasc Res (2007) 0.80
Requirement for functional BK channels in maintaining oscillation in venomotor tone revealed by species differences in expression of the β1 accessory subunits. J Cardiovasc Pharmacol (2012) 0.80
Role of a responsive sympathetic nervous system in the chronic hypotensive effects of losartan in normal rats. J Cardiovasc Pharmacol (2005) 0.80
Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2004) 0.79
The fenfluramine metabolite (+)-norfenfluramine is vasoactive. J Pharmacol Exp Ther (2004) 0.79
BK channel β1-subunit deficiency exacerbates vascular fibrosis and remodelling but does not promote hypertension in high-fat fed obesity in mice. J Hypertens (2015) 0.77
Alpha-1B adrenoceptors mediate neurogenic constriction in mesenteric arteries of normotensive and DOCA-salt hypertensive mice. Auton Neurosci (2005) 0.77
CE coupled with amperometric detection using a boron-doped diamond microelectrode: validation of a method for endogenous norepinephrine analysis in tissue. Electrophoresis (2008) 0.77
Increased reactivity of murine mesenteric veins to adrenergic agonists: functional evidence supporting increased alpha1-adrenoceptor reserve in veins compared with arteries. J Pharmacol Exp Ther (2003) 0.77
Effects of intrathecal kynurenate on arterial pressure during chronic osmotic stress in conscious rats. Am J Physiol Heart Circ Physiol (2012) 0.77
High-fat food, sympathetic nerve activity, and hypertension: danger soon after the first bite? Hypertension (2012) 0.77
Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model. J Cardiovasc Pharmacol (2010) 0.77
Differential contributions of alpha-1 and alpha-2 adrenoceptors to vasoconstriction in mesenteric arteries and veins of normal and hypertensive mice. Vascul Pharmacol (2007) 0.76
Direct assessment of organ specific sympathetic nervous system activity in normal and cardiovascular disease states. Exp Physiol (2010) 0.76
Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function. J Cardiovasc Pharmacol (2006) 0.76
Chronic hypotensive effects of losartan are not dependent on the actions of angiotensin II at AT 2 receptors. J Cardiovasc Pharmacol (2002) 0.76
A custom rat and baboon hypertension gene array to compare experimental models. Exp Biol Med (Maywood) (2012) 0.75
Reply from V. A. Averina, H. G. Othmer, G. D. Fink and J. W. Osborn. J Physiol (2013) 0.75